ARCHIVES

Watson, Weinstein Decide FCRC Isn’t So Bad After all; DCCP to Develop RFAs, RFPs With Help Of Workshops

This article is from The Cancer Letter archive.

Vol. 05 No. 19 | May 11, 1979

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

ASCO Updates Guideline On Antiemetics

June 30, 2006

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

Committee Discusses Cap On Center Grants, New Guidelines

October 18, 1991